S Barbey

426 total citations
28 papers, 351 citations indexed

About

S Barbey is a scholar working on Immunology, Physiology and Molecular Biology. According to data from OpenAlex, S Barbey has authored 28 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in S Barbey's work include Histiocytic Disorders and Treatments (8 papers), Mast cells and histamine (6 papers) and Cell Adhesion Molecules Research (4 papers). S Barbey is often cited by papers focused on Histiocytic Disorders and Treatments (8 papers), Mast cells and histamine (6 papers) and Cell Adhesion Molecules Research (4 papers). S Barbey collaborates with scholars based in France, Morocco and Israel. S Barbey's co-authors include C Nézelof, Jean Gogusev, J L Virelizier, Michel Kornprobst, F Arenzana-Seisdedos, Francis Jaubert, Martine Papiernik, Wilson Savino, Christiane Pontoux and B Nabarra and has published in prestigious journals such as Journal of Clinical Investigation, International Journal of Cancer and Cellular and Molecular Life Sciences.

In The Last Decade

S Barbey

27 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S Barbey France	10	187	144	72	70	65	28	351
Bhumi Patel United States	7	126 0.7×	80 0.6×	150 2.1×	41 0.6×	52 0.8×	9	378
K Kasahara Japan	12	97 0.5×	200 1.4×	104 1.4×	12 0.2×	22 0.3×	22	400
C. Nilsson United States	6	129 0.7×	222 1.5×	46 0.6×	16 0.2×	11 0.2×	9	366
T. KAMEYAMA Japan	9	103 0.6×	134 0.9×	54 0.8×	6 0.1×	35 0.5×	12	356
Kimiko Kasahara Japan	11	92 0.5×	189 1.3×	126 1.8×	8 0.1×	21 0.3×	29	394
Orietta D’Orlando Germany	9	60 0.3×	322 2.2×	98 1.4×	14 0.2×	23 0.4×	10	435
G. Avanzi Italy	6	56 0.3×	92 0.6×	235 3.3×	19 0.3×	23 0.4×	16	391
M Svenson Denmark	9	40 0.2×	236 1.6×	48 0.7×	11 0.2×	16 0.2×	9	398
Alexandra Joseph United States	7	85 0.5×	162 1.1×	51 0.7×	54 0.8×	6 0.1×	8	378
N. Noso Germany	7	190 1.0×	219 1.5×	43 0.6×	9 0.1×	21 0.3×	8	406

Countries citing papers authored by S Barbey

Since Specialization

Citations

This map shows the geographic impact of S Barbey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Barbey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Barbey more than expected).

Fields of papers citing papers by S Barbey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Barbey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Barbey. The network helps show where S Barbey may publish in the future.

Co-authorship network of co-authors of S Barbey

This figure shows the co-authorship network connecting the top 25 collaborators of S Barbey. A scholar is included among the top collaborators of S Barbey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Barbey. S Barbey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barbey, S, Letizia Venturini, N Balitrand, et al.. (1995). In vitro treatment with retinoids or the topoisomerase inhibitor, VP-16, evidences different functional apoptotic pathways in acute promyelocytic leukemic cells.. PubMed. 9(12). 2049–57. 17 indexed citations

Barbey, S, et al.. (1992). 45. Regulation of BcI-2 and cell death by all-trans retinoic acid in acute promyelocytic leukemic cells. Biomedicine & Pharmacotherapy. 46(5-7). 260–260. 6 indexed citations

Gogusev, Jean, S Barbey, & C Nézelof. (1991). Human malignant histiocytosis CD30+ DEL cell line differentiates into macrophage-like cells when treated with a phorbol diester.. PubMed. 51(20). 5712–5. 5 indexed citations

Barbey, S, et al.. (1990). Del cell line: A “malignant histiocytosis” CD30 + T(5;6)(Q35;P21) cell line. International Journal of Cancer. 45(3). 546–553. 18 indexed citations

Gogusev, Jean, S Barbey, & C Nézelof. (1990). Genotype markers and proto‐oncogene analysis in the cd30‐positive “malignant histiocytosis” del cell line with t(5;6)(q35;p21). International Journal of Cancer. 46(1). 106–112. 13 indexed citations

Barbey, S, et al.. (1987). Histiocytes X and X Body Reactivity with Concanavalin A, Peanut Agglutinin and BSPT. Pathology - Research and Practice. 182(6). 805–809. 3 indexed citations

Barbey, S, et al.. (1987). Histiocytosis X Langerhans Cells React with Antiinterleukin-2 Receptor Monoclonal Antibody. Pediatric Pathology. 7(5-6). 569–574. 15 indexed citations

Barbey, S, et al.. (1987). Histiocytes X and X Body Reactivity with Concanavalin A, Peanut Agglutinin and BSPT. Pathology - Research and Practice. 182(5). 669–675. 7 indexed citations

Arenzana-Seisdedos, F, S Barbey, J L Virelizier, Michel Kornprobst, & C Nézelof. (1986). Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture.. Journal of Clinical Investigation. 77(1). 326–329. 77 indexed citations

10.

Barbey, S & C Nèzelof. (1986). [The Langerhans system. Definition. Physiologic and pathologic modifications].. PubMed. 34(4). 259–73. 4 indexed citations

11.

Nézelof, C & S Barbey. (1985). Histiocytosis: Nosology and Pathobiology. Pediatric Pathology. 3(1). 1–41. 44 indexed citations

12.

Barbey, S, et al.. (1985). Failure of Histiocytosis X Cells to Express i Blood Group Antigen. Pathology - Research and Practice. 180(6). 584–589. 5 indexed citations

13.

Rousseau-Merck, M.F., S Barbey, Francis Jaubert, et al.. (1983). Reactivity of Histiocytosis X Cells with Monoclonal Antibodies. Pathology - Research and Practice. 177(1). 8–12. 17 indexed citations

14.

Papiernik, Martine, B Nabarra, Wilson Savino, Christiane Pontoux, & S Barbey. (1983). Thymic reticulum in mice II. Culture and characterization of nonepithelial phagocytic cells of the thymic reticulum: Their role in the syngeneic stimulation of thymic medullary lymphocytes. European Journal of Immunology. 13(2). 147–155. 41 indexed citations

15.

Barbey, S, Francis Jaubert, J.C. Mazière, M. Grün, & C Nézelof. (1982). Lipid synthesis and storage by histiocytes X. Study "in vitro" for eosinophilic granuloma.. PubMed. 30(3). 147–50. 3 indexed citations

16.

Barbey, S, Francis Jaubert, M. Grün, & C Nézelof. (1982). Skin Langerhans cells failure to trap bacterial antigen in non-sensitized guinea-pig.. PubMed. 132D(1). 111–24. 5 indexed citations

17.

Jaubert, Francis, et al.. (1980). Histiocyte X positivity for nonspecific esterase.. Journal of Histochemistry & Cytochemistry. 28(1). 45–46. 15 indexed citations

18.

Rousseau-Merck, M.F., S Barbey, Hélène Mouly, S Bazin, & C Nézelof. (1979). Collagenolytic activity of eosinophilic granuloma in vitro. Cellular and Molecular Life Sciences. 35(9). 1226–1228. 5 indexed citations

19.

Barbey, S & Adam Borit. (1976). Acid esterase in human arteries. Histochemistry and Cell Biology. 49(1). 37–41. 1 indexed citations

20.

Nézelof, C, et al.. (1974). [Histocytosis-X. Histochemical and autoradiographic elements proving lipid synthesis in in vitro culture].. PubMed. 20(6). 414–24. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact